Statistics for Atea Pharmaceuticals (id:8174 AVIR)
Valuation metrics
Market cap
267.75M
Enterprise value
-213,230,096.00
Trailing P/E (ttm)
-2.07
Forward P/E
-2.07
PEG ratio
-2.07
Price/Sales (ttm)
Price/Book (mrq)
0.58
Enterprise Value/Revenue
Enterprise Value/EBITDA
1.71
Overview
Shares outstanding
84.46M
Float
64.31M
Shares short
2.59M
% Held by insiders
0.10%
% Held by institutions
0.71%
Average volume (10 days)
226.35K
Average volume (90 days)
Price summary
52-Week low
2.81
52-Week high
4.60
52-Week change
14.54%
Beta
0.17
50-Day moving average
3.51
200-Day moving average
3.72
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-14.25%
Return on equity
-33.46%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-124,883,000.00
Net income to common (ttm)
-174,006,000.00
Diluted EPS (ttm)
-2.07
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
482.81M
Total cash per share (mrq)
5.72
Total debt (mrq)
1.84M
Total Debt/Equity (mrq)
0.40
Current ratio (mrq)
1.93K%
Book value per share (mrq)
5.43
Cash flow
Cash flow statement
-126,936,000.00
Levered free cash flow (LFCF)
-17,914,876.00